A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
News Medical on MSN
Diabetes drugs semaglutide and tirzepatide show real-world heart benefits
In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack ...
In traditional medicine, mad honey is used to treat sore throat, flu, diabetes, gastritis, hypertension, and arthritis ...
This news was covered by the Medical Dialogues Bureau, which was present at the TCT Conference 2025 held in San Francisco, USA.Use of the NyokAssist small-bore percutaneous ventricular ...
An Indian medical innovation has achieved a major global recognition with a new generation heart stent manufactured in India achieving a lower failure rate in high-risk patients against a US-made ...
The Chosun Ilbo on MSN
Genetic Testing Advances Herald 'Super Baby' Era
Predictive indicators for whether a child will be vulnerable to certain diseases after birth, as well as their future height, ...
In the TUXEDO-II Trial, which compared Supraflex Cruz with Xience in diabetic patients with multivessel disease, 1,800 patients were enrolled across 66 sites in India under the leadership of ...
New evidence from five randomized trials suggests that withholding β-blockers after myocardial infarction (MI) is safe for carefully selected, low-risk patients. However, even if β-blockers are not ...
Background Primary percutaneous coronary intervention (PCI) has significantly improved outcomes for ST-segment elevation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback